Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)Muhammad Furqan, Gerald H. Clamon, Travis Snyders et al.|Cancer Medicine|2019Cited by 12
Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survivalJoshua B. Kaelberer, John M. Watkins, Michael A. O’Donnell et al.|Prostate International|2016Cited by 10
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy AloneSteven N. Seyedin, John M. Watkins, Darrion Mitchell et al.|Pathology & Oncology Research|2017Cited by 9
The impact of prostate cancer (PC) margin extent (ME) at radical prostatectomy (RP) on biochemical relapse-free survival (bRFS).Steven N. Seyedin, John M. Watkins, Anthony N. Snow et al.|Journal of Clinical Oncology|2018Cited by 2
A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation TherapySteven N. Seyedin, Joseph M. Caster, John M. Watkins et al.|Advances in Radiation Oncology|2021Cited by 2